NewMarket Past Earnings Performance
Past criteria checks 5/6
NewMarket has been growing earnings at an average annual rate of 8.3%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 6.5% per year. NewMarket's return on equity is 34.6%, and it has net margins of 14.8%.
Key information
8.3%
Earnings growth rate
12.5%
EPS growth rate
Chemicals Industry Growth | 12.4% |
Revenue growth rate | 6.5% |
Return on equity | 34.6% |
Net Margin | 14.8% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How NewMarket makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 2,692 | 398 | 118 | 136 |
31 Dec 23 | 2,698 | 388 | 114 | 138 |
30 Sep 23 | 2,738 | 398 | 114 | 133 |
30 Jun 23 | 2,767 | 350 | 112 | 136 |
31 Mar 23 | 2,805 | 317 | 113 | 137 |
31 Dec 22 | 2,765 | 279 | 110 | 140 |
30 Sep 22 | 2,659 | 206 | 108 | 143 |
30 Jun 22 | 2,585 | 194 | 118 | 144 |
31 Mar 22 | 2,452 | 180 | 116 | 144 |
31 Dec 21 | 2,356 | 190 | 120 | 144 |
30 Sep 21 | 2,307 | 240 | 125 | 145 |
30 Jun 21 | 2,198 | 284 | 117 | 143 |
31 Mar 21 | 2,018 | 254 | 118 | 141 |
31 Dec 20 | 2,011 | 270 | 117 | 140 |
30 Sep 20 | 2,018 | 253 | 119 | 140 |
30 Jun 20 | 2,061 | 225 | 122 | 143 |
31 Mar 20 | 2,213 | 277 | 124 | 147 |
31 Dec 19 | 2,190 | 254 | 125 | 144 |
30 Sep 19 | 2,194 | 267 | 120 | 141 |
30 Jun 19 | 2,202 | 257 | 120 | 140 |
31 Mar 19 | 2,237 | 236 | 128 | 139 |
31 Dec 18 | 2,290 | 234 | 134 | 140 |
30 Sep 18 | 2,311 | 176 | 147 | 140 |
30 Jun 18 | 2,297 | 177 | 150 | 142 |
31 Mar 18 | 2,245 | 187 | 153 | 142 |
31 Dec 17 | 2,198 | 190 | 154 | 146 |
30 Sep 17 | 2,140 | 232 | 154 | 152 |
30 Jun 17 | 2,108 | 243 | 160 | 152 |
31 Mar 17 | 2,082 | 245 | 157 | 156 |
31 Dec 16 | 2,049 | 243 | 154 | 161 |
30 Sep 16 | 2,027 | 251 | 163 | 156 |
30 Jun 16 | 2,052 | 242 | 163 | 158 |
31 Mar 16 | 2,091 | 236 | 163 | 158 |
31 Dec 15 | 2,141 | 238 | 164 | 158 |
30 Sep 15 | 2,210 | 236 | 162 | 154 |
30 Jun 15 | 2,259 | 231 | 166 | 151 |
31 Mar 15 | 2,319 | 239 | 166 | 147 |
31 Dec 14 | 2,335 | 233 | 164 | 139 |
30 Sep 14 | 2,343 | 235 | 165 | 137 |
30 Jun 14 | 2,334 | 235 | 164 | 137 |
31 Mar 14 | 2,297 | 233 | 163 | 138 |
31 Dec 13 | 2,280 | 242 | 165 | 137 |
30 Sep 13 | 2,237 | 240 | 161 | 135 |
30 Jun 13 | 2,208 | 247 | 157 | 129 |
Quality Earnings: UG9 has high quality earnings.
Growing Profit Margin: UG9's current net profit margins (14.8%) are higher than last year (11.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UG9's earnings have grown by 8.3% per year over the past 5 years.
Accelerating Growth: UG9's earnings growth over the past year (25.5%) exceeds its 5-year average (8.3% per year).
Earnings vs Industry: UG9 earnings growth over the past year (25.5%) exceeded the Chemicals industry -19.4%.
Return on Equity
High ROE: Whilst UG9's Return on Equity (34.63%) is high, this metric is skewed due to their high level of debt.